CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Jan. 31, 2024	Sep. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss					$ (57,314,000)	$ (22,220,000)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization					6,210,000	4,730,000
Impairment of investment in non-affiliate						2,250,000
Goodwill impairment		$ 0	$ 24,929,000	$ 0	24,929,000	0	$ 0
Provision for warranty expense					618,000	(837,000)
Non-cash lease expense					599,000	1,079,000
Stock-based compensation					7,081,000	9,523,000
Change in fair value of earnout related to acquisition					(294,000)	140,000
Non-cash interest expense					104,000	107,000
Provision for excess and obsolete inventory					3,852,000	2,697,000
Provision for expected credit losses					(328,000)	804,000
Non-cash legal expense (Note 12 "Commitments and Contingencies")	$ 140,000					7,255,000
Change in operating assets and liabilities
Accounts receivable					7,861,000	(1,739,000)
Inventory					3,390,000	(2,020,000)
Deferred cost of revenue					7,071,000	8,175,000
Prepaid expenses and other assets					(4,617,000)	4,474,000
Accounts payable					1,950,000	(5,581,000)
Accrued expenses and other liabilities					(1,131,000)	(5,338,000)
Deferred revenue					(28,911,000)	(23,189,000)
Lease liabilities					(302,000)	(1,208,000)
Net cash used in operating activities					(29,232,000)	(20,898,000)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment					(3,552,000)	(524,000)
Capitalized software costs					(3,389,000)	(4,501,000)
Net cash used in investing activities					(6,941,000)	(5,025,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments for repurchases of Class A common stock					(4,918,000)	(23,462,000)
Proceeds from options exercise						2,000
Proceeds from ESPP purchases					285,000	586,000
Taxes paid related to net share settlements of stock-based compensation awards					(897,000)	(1,849,000)
Payment of earnout related to acquisition					(1,466,000)	(1,530,000)
Net cash used in financing activities					(6,996,000)	(26,253,000)
Effect of exchange rate changes on cash and cash equivalents					709,000	117,000
Net decrease in cash, cash equivalents, and restricted cash					(42,460,000)	(52,059,000)
Cash, cash equivalents, and restricted cash - beginning of period	$ 215,709,000		$ 142,482,000		142,482,000	215,709,000	215,709,000
Cash, cash equivalents, and restricted cash - end of period		100,022,000		163,650,000	100,022,000	163,650,000	142,482,000
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents		100,022,000		163,403,000	100,022,000	163,403,000	142,482,000
Restricted cash, current portion				247,000		247,000
Total cash, cash equivalents, and restricted cash		$ 100,022,000		$ 163,650,000	100,022,000	163,650,000	$ 142,482,000
Supplemental disclosure of cash flow information
Interest paid					128,000	182,000
Cash paid for income taxes					340,000	165,000
Schedule of non-cash investing and financing activities
Right-of-use ("ROU") assets obtained in exchange for new lease liabilities						6,235,000
Accrued property and equipment at period end					8,000	83,000
Stock repurchases excise tax charged to equity					$ 13,000	$ 151,000